# Adjunctive Ivermectin Mass Drug Administration for Malaria Control

> **NCT04844905** · PHASE3 · UNKNOWN · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 24000 (estimated)

## Conditions studied

- Malaria,Falciparum
- Neglected Tropical Diseases
- Strongyloidiasis
- Lymphatic Filariasis
- Scabies
- Hook Worm
- Soil Transmitted Helminths

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Placebo
- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT04844905
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-03
- **Primary completion:** 2023-03
- **Final completion:** 2023-08
- **Target enrollment:** 24000 (ESTIMATED)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04844905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04844905, "Adjunctive Ivermectin Mass Drug Administration for Malaria Control". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04844905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*